Overexpression of a disintegrin and metalloproteinase 9 (ADAM9) in relation to poor prognosis of patients with oral squamous cell carcinoma
- PMID: 39441449
- PMCID: PMC11499557
- DOI: 10.1007/s12672-024-01422-1
Overexpression of a disintegrin and metalloproteinase 9 (ADAM9) in relation to poor prognosis of patients with oral squamous cell carcinoma
Abstract
This study investigates the expressions of ADAM9, CDCP1 and t-PA in OSCC and their impacts on patient prognosis. Previous research has demonstrated the overexpression of ADAM9 and activation of plasminogen activator in OSCC, but CDCP1's role remains unexplored. While these biomolecules are known to contribute to lung cancer metastasis, their concurrent expressions in OSCC have not been thoroughly examined. Our aim is to assess the expressions of ADAM9, CDCP1, and t-PA in OSCC specimens, compare them with normal oral tissues, and explore their correlation with OSCC's clinicopathological features and patient survival outcomes.
Keywords: A disintegrin and metalloproteinase 9; CUB domain-containing protein 1; Oral squamous cell carcinoma; Overexpression; Tissue-type plasminogen activato.
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Overexpression of ADAM9 in oral squamous cell carcinoma.Oncol Lett. 2018 Jan;15(1):495-502. doi: 10.3892/ol.2017.7284. Epub 2017 Oct 30. Oncol Lett. 2018. PMID: 29285199 Free PMC article.
-
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis.Oncotarget. 2017 Jul 18;8(29):47365-47378. doi: 10.18632/oncotarget.17648. Oncotarget. 2017. PMID: 28537886 Free PMC article.
-
Involvement of the A disintegrin and metalloproteinase 9 in oral cancer cell invasion.Eur J Oral Sci. 2021 Jun;129(3):e12775. doi: 10.1111/eos.12775. Epub 2021 Mar 30. Eur J Oral Sci. 2021. PMID: 33786875
-
Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis.Arch Oral Biol. 2020 Jun;114:104717. doi: 10.1016/j.archoralbio.2020.104717. Epub 2020 Apr 11. Arch Oral Biol. 2020. PMID: 32344357 Review.
-
Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma.Int J Mol Sci. 2018 Aug 16;19(8):2413. doi: 10.3390/ijms19082413. Int J Mol Sci. 2018. PMID: 30115834 Free PMC article. Review.
References
-
- Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188–96. - PubMed
-
- Sun S, Zhang Z. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization. Front Med. 2016;10:104–10. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous